BridgeBio Pharma (BBIO) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.17% |
| Dec 31, 2025 | -109.00% |
| Sep 30, 2025 | 63.05% |
| Jun 30, 2025 | -40.77% |
| Mar 31, 2025 | 20.91% |
| Dec 31, 2024 | -162.67% |
| Sep 30, 2024 | 52.37% |
| Jun 30, 2024 | -15.81% |
| Mar 31, 2024 | -9.31% |
| Dec 31, 2023 | 14.04% |
| Sep 30, 2023 | -58.81% |
| Jun 30, 2023 | 26.22% |
| Mar 31, 2023 | -4.28% |
| Dec 31, 2022 | 26.38% |
| Sep 30, 2022 | 19.02% |
| Jun 30, 2022 | -6.80% |
| Mar 31, 2022 | -62.21% |
| Dec 31, 2021 | 34.54% |
| Sep 30, 2021 | 28.61% |
| Jun 30, 2021 | 8.94% |
| Mar 31, 2021 | -67,988.09% |
| Dec 31, 2020 | 100.19% |
| Sep 30, 2020 | 15.60% |
| Jun 30, 2020 | 6.99% |
| Mar 31, 2020 | -149.53% |
| Dec 31, 2019 | 32.23% |
| Sep 30, 2019 | -81.69% |
| Jun 30, 2019 | 21.24% |
| Mar 31, 2019 | 14.48% |
| Dec 31, 2018 | -106.80% |
| Sep 30, 2018 | 15.40% |